ONO Pharmaceutical Co. Ltd.

06/04/2024 | Press release | Distributed by Public on 06/03/2024 22:06

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients[...]

 This material is intended to notify the press release issued on May 29 (local time) by Bristol Myers Squibb, our license partner for Opdivo.
 Please click https://www.bms.com/media/press-releases.html for the original press release.